Ona Therapeutics Advances As A Clinical-Stage Company And Appoints Aleix Prat, MD, Phd, As Chief Medical Officer

(MENAFN - GlobeNewsWire - Nasdaq) More than half of the patients planned for the clinical study have already been enrolled, with the trial progressing rapidly through dose escalation Advancement ...